Farid A Badria

Title: Farid A Badria: Innovator in Nanoformulation for Cancer Treatment

Introduction

Farid A Badria is a prominent inventor based in Riyadh, Saudi Arabia. He has made significant contributions to the field of medical science, particularly in the area of cancer treatment. His innovative work focuses on the development of novel nanoformulations that can enhance therapeutic efficacy.

Latest Patents

Farid A Badria holds a patent for a groundbreaking invention titled "Nanoformulation of spirooxindole and methods for treating hepatocellular carcinoma." This patent describes a spirooxindole nanoformulation that includes a proniosome loaded with a spirooxindole derivative. The specific compound involved in this formulation is identified as Compound 4d. This innovative approach aims to improve treatment outcomes for patients suffering from hepatocellular carcinoma.

Career Highlights

Farid A Badria is affiliated with King Saud University, where he contributes to research and development in the field of pharmaceutical sciences. His work is characterized by a commitment to advancing medical treatments through innovative formulations and methodologies.

Collaborations

Farid collaborates with esteemed colleagues, including Assem Barakat and Fardous F El-Senduny. These partnerships enhance the research efforts and contribute to the development of effective treatment options.

Conclusion

Farid A Badria's contributions to the field of cancer treatment through his innovative nanoformulation techniques highlight his role as a leading inventor. His work not only showcases his expertise but also holds the potential to significantly impact patient care in oncology.